202 related articles for article (PubMed ID: 15657574)
21. Adjuvant radioactive therapy after reoperation for locoregionally recurrent papillary thyroid cancer in patients who initially underwent total thyroidectomy and high-dose remnant ablation.
Yim JH; Kim WB; Kim EY; Kim WG; Kim TY; Ryu JS; Moon DH; Sung TY; Yoon JH; Kim SC; Hong SJ; Shong YK
J Clin Endocrinol Metab; 2011 Dec; 96(12):3695-700. PubMed ID: 21976723
[TBL] [Abstract][Full Text] [Related]
22. [Outcome of reoperation for thyroid cancer: clinical analysis of 72 cases].
Shi L; Cheng B; Qu XC; Liu CP; Huang T
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):871-3. PubMed ID: 17953827
[TBL] [Abstract][Full Text] [Related]
23. The long term outcome of papillary thyroid carcinoma patients without primary central lymph node dissection: expected improvement of routine dissection.
Giles Senyurek Y; Tunca F; Boztepe H; Alagöl F; Terzioglu T; Tezelman S
Surgery; 2009 Dec; 146(6):1188-95. PubMed ID: 19958948
[TBL] [Abstract][Full Text] [Related]
24. Central neck lymph node dissection for papillary thyroid cancer: comparison of complication and recurrence rates in 295 initial dissections and reoperations.
Shen WT; Ogawa L; Ruan D; Suh I; Kebebew E; Duh QY; Clark OH
Arch Surg; 2010 Mar; 145(3):272-5. PubMed ID: 20231628
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
[TBL] [Abstract][Full Text] [Related]
26. Extrathyroidal extension is not all equal: Implications of macroscopic versus microscopic extent in papillary thyroid carcinoma.
Arora N; Turbendian HK; Scognamiglio T; Wagner PL; Goldsmith SJ; Zarnegar R; Fahey TJ
Surgery; 2008 Dec; 144(6):942-7; discussion 947-8. PubMed ID: 19041001
[TBL] [Abstract][Full Text] [Related]
27. [Is the timing of completion thyroidectomy for differentiated thyroid carcinoma prognostic significant?].
Walgenbach S; Junginger T
Zentralbl Chir; 2002 May; 127(5):435-8. PubMed ID: 12058304
[TBL] [Abstract][Full Text] [Related]
28. Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control.
Sugitani I; Fujimoto Y; Yamamoto N
Surgery; 2008 Jan; 143(1):35-42. PubMed ID: 18154931
[TBL] [Abstract][Full Text] [Related]
29. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer.
Shindo M; Wu JC; Park EE; Tanzella F
Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):650-4. PubMed ID: 16785411
[TBL] [Abstract][Full Text] [Related]
30. Predictive factors of level IIb lymph node metastasis in patients with papillary thyroid carcinoma.
Koo BS; Yoon YH; Kim JM; Choi EC; Lim YC
Ann Surg Oncol; 2009 May; 16(5):1344-7. PubMed ID: 19224280
[TBL] [Abstract][Full Text] [Related]
31. Disparities between male and female patients with thyroid cancers: sex difference or gender divide?
Machens A; Hauptmann S; Dralle H
Clin Endocrinol (Oxf); 2006 Oct; 65(4):500-5. PubMed ID: 16984243
[TBL] [Abstract][Full Text] [Related]
32. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.
Koo BS; Choi EC; Yoon YH; Kim DH; Kim EH; Lim YC
Ann Surg; 2009 May; 249(5):840-4. PubMed ID: 19387316
[TBL] [Abstract][Full Text] [Related]
33. Safety of completion thyroidectomy following unilateral lobectomy for well-differentiated thyroid cancer.
Kupferman ME; Mandel SJ; DiDonato L; Wolf P; Weber RS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1209-12. PubMed ID: 12169901
[TBL] [Abstract][Full Text] [Related]
34. Papillary thyroid carcinoma: factors influencing recurrence and survival.
Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
[TBL] [Abstract][Full Text] [Related]
35. [The utility of aspiration cytology for the distinction of aggressive and non-aggressive papillary carcinoma of the thyroid].
Caprara G; Collina G
Pathologica; 2007 Jun; 99(3):65-8. PubMed ID: 17987724
[TBL] [Abstract][Full Text] [Related]
36. [Risk factors in papillary thyroid cancer].
Wagner HE; Birrer A; Lüscher B; Kinser J; Rösler H
Helv Chir Acta; 1993 Jun; 59(5-6):819-23. PubMed ID: 8376147
[TBL] [Abstract][Full Text] [Related]
37. Clinical recurrence of papillary thyroid cancer in the remnant lobe.
Asanuma K; Kobayashi S; Sugenoya A; Yokoyama S; Shingu K; Hama Y; Itoh N; Kasuga Y; Amano J
Eur J Surg; 2000 Mar; 166(3):202-6. PubMed ID: 10755332
[TBL] [Abstract][Full Text] [Related]
38. Recurrent laryngeal nerve paralysis in patients with papillary thyroid carcinomas: evaluation and management of resulting vocal dysfunction.
Roh JL; Yoon YH; Park CI
Am J Surg; 2009 Apr; 197(4):459-65. PubMed ID: 18848696
[TBL] [Abstract][Full Text] [Related]
39. Followup of patients with papillary thyroid cancer: in search of the optimal algorithm.
Mittendorf EA; Wang X; Perrier ND; Francis AM; Edeiken BS; Shapiro SE; Lee JE; Evans DB
J Am Coll Surg; 2007 Aug; 205(2):239-47. PubMed ID: 17660070
[TBL] [Abstract][Full Text] [Related]
40. Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer.
Farrag TY; Lin FR; Cummings CW; Koch WM; Flint PW; Califano JA; Broussard J; Bajaj G; Tufano RP
Laryngoscope; 2006 Oct; 116(10):1864-6. PubMed ID: 17003711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
